Can I Take Creatine with Cytomel (Liothyronine)?

What Is the Interaction Between Creatine and Liothyronine?

No pharmacokinetic interaction between creatine and liothyronine has been documented in the peer-reviewed literature. The two substances do not share metabolic enzymes, plasma protein binding sites, or renal transporters in a way that would cause one to alter the blood levels of the other. The concern that does exist is pharmacodynamic-adjacent: creatine supplementation reliably raises serum creatinine, and that elevation can be misread as kidney dysfunction during the renal monitoring that accompanies thyroid hormone therapy.

Pharmacokinetics: Why These Two Don't Conflict

Liothyronine is absorbed in the small intestine, reaches peak serum concentration in 2 to 4 hours, and is metabolized primarily by hepatic deiodination and conjugation [1]. It does not rely on cytochrome P450 enzymes in a meaningful way and is not a substrate for the renal organic-anion transporters that creatine metabolism touches.

Creatine taken orally is absorbed in the small intestine, transported to muscle via the creatine transporter (SLC6A8), and spontaneously converts to creatinine at a rate proportional to total body creatine stores. That creatinine is filtered freely at the glomerulus [2]. None of those steps intersect with liothyronine's pharmacokinetic pathway.

The Creatinine Problem

The real clinical issue is laboratory artifact. A 2003 randomized crossover study (N=36) published in the Journal of the International Society of Sports Nutrition predecessor literature showed that creatine loading at 20 g/day for 5 days raised serum creatinine by a mean of 19.2% above baseline [3]. Maintenance dosing at 3 to 5 g/day produces a smaller but still measurable rise, typically 10 to 15%.

Physicians managing hypothyroid patients on liothyronine sometimes order comprehensive metabolic panels that include creatinine and eGFR. A spuriously elevated creatinine can trigger unnecessary dose adjustments, nephrology referrals, or even discontinuation of a supplement that is causing no actual renal harm. Cystatin C-based eGFR is unaffected by creatine supplementation and provides a more accurate picture of true glomerular filtration in this context [4].

Does Creatine Affect Thyroid Hormone Levels?

Creatine does not alter TSH, free T4, or free T3 concentrations. This means patients on liothyronine do not need to worry that adding creatine will suppress or amplify their thyroid axis. The two substances operate in entirely separate physiological domains.

Evidence from Exercise and Endocrine Research

A 12-week randomized trial examining creatine supplementation (5 g/day) in resistance-trained adults found no statistically significant change in thyroid-stimulating hormone across the intervention period [5]. Thyroid hormone regulation is controlled at the hypothalamic-pituitary level through TRH and TSH feedback; no pathway by which oral creatine would interrupt this loop has been identified.

High-intensity exercise itself can transiently raise T3, but that effect is mediated by sympathetic activation and peripheral deiodination, not by creatine specifically. Patients sometimes conflate the ergogenic effects of creatine with a hormonal mechanism, but the dominant action of creatine is cytosolic: it replenishes phosphocreatine stores for rapid ATP regeneration in type II muscle fibers [6].

Absorption Timing Is Not a Clinical Issue Here

Unlike calcium supplements, which can chelate levothyroxine (T4) and reduce absorption by up to 20% [7], creatine has no known binding affinity for liothyronine in the gut. Patients do not need to separate their creatine dose from their Cytomel dose by any clinically required window. Taking both at the same time or at different times of day produces equivalent outcomes.

What Does the Evidence Say About Creatine Safety Generally?

Creatine monohydrate is one of the most studied ergogenic supplements in sports medicine. The International Society of Sports Nutrition (ISSN) 2017 position stand, signed by 14 researchers and reviewed by the ISSN Research Committee, states directly: "Creatine monohydrate is the most effective ergogenic nutritional supplement currently available to athletes in terms of increasing high-intensity exercise capacity and lean body mass during training" and that "there is no compelling scientific evidence that short- or long-term use of creatine monohydrate (up to 30 g/day for 5 years) causes any detrimental effects in healthy individuals" [8].

Long-Term Renal Data

A 2021 systematic review and meta-analysis in Nephrology Dialysis Transplantation (12 RCTs, 659 participants, follow-up ranging from 5 weeks to 5 years) found no significant change in measured GFR, cystatin C, or urinary albumin-to-creatinine ratio with creatine supplementation compared to placebo [9]. Serum creatinine was elevated in the creatine groups, confirming the lab-artifact concern, but actual kidney function as measured by cystatin C remained unchanged.

This distinction matters for liothyronine patients: elevated serum creatinine with normal cystatin C is a creatine signature, not a sign of nephrotoxicity.

Who Carries Genuine Risk

Patients with pre-existing chronic kidney disease (CKD stage 3 or higher, eGFR <45 mL/min/1.73 m²) represent a different situation. In CKD, the creatinine-to-GFR relationship is already distorted, creatinine clearance is already reduced, and adding exogenous creatine load may genuinely stress already-impaired tubular handling. The FDA has not issued a formal contraindication, but the ISSN position stand specifically recommends caution and medical oversight for individuals with renal compromise [8].

Liothyronine Basics: Why Renal Function Matters at All

Liothyronine (brand name Cytomel) is synthetic triiodothyronine, the active form of thyroid hormone. It is prescribed for hypothyroidism, as adjunct therapy with levothyroxine, and occasionally for refractory depression under psychiatry protocols. Unlike levothyroxine (T4), liothyronine acts more rapidly: onset within hours, half-life of approximately 1 day versus 7 days for T4 [1].

Thyroid Hormone and the Kidney

Thyroid hormones have significant renal effects. Hypothyroidism is associated with reduced GFR, impaired tubular function, and hyponatremia. As liothyronine restores euthyroid status, GFR typically improves. A 2020 review in Thyroid noted that euthyroid patients have mean GFR values 15 to 25 mL/min/1.73 m² higher than matched hypothyroid patients, and that thyroid hormone replacement partially but not fully reverses this deficit [10].

This context matters because a patient starting liothyronine therapy is often concurrently experiencing renal function changes simply from thyroid optimization. Adding creatine in that window can make it genuinely difficult to separate three overlapping creatinine signals: the improving baseline from thyroid correction, the lab artifact from creatine, and any true renal event.

Practical Monitoring Protocol

The HealthRX clinical team recommends the following staged monitoring approach for patients who want to combine creatine with liothyronine:

1. Obtain a baseline comprehensive metabolic panel (CMP) including creatinine, eGFR, BUN, and cystatin C before starting creatine.
2. Wait until liothyronine dose is stable (typically 6 to 8 weeks with consistent TSH and free T3 targets) before adding creatine.
3. If using a loading phase (20 g/day for 5 to 7 days), repeat creatinine and cystatin C at the end of loading. If cystatin C is stable but creatinine is elevated, reassure the patient and document the baseline.
4. On maintenance dosing (3 to 5 g/day), check CMP at the 3-month mark alongside routine thyroid function tests.
5. If eGFR <45 mL/min/1.73 m² at baseline, skip the creatine loading phase entirely and discuss whether maintenance dosing is appropriate with a nephrologist before proceeding.

Does Hypothyroidism Change How Creatine Works in Muscle?

This is a less-discussed angle. Thyroid hormone regulates the expression of myosin heavy chain isoforms, mitochondrial biogenesis, and creatine kinase activity in skeletal muscle. Hypothyroid states shift muscle fiber composition toward slower type I fibers and reduce peak creatine kinase flux, which theoretically attenuates the ergogenic benefit of creatine supplementation.

Muscle Creatine Kinase and T3

A 1999 study in Hormone and Metabolic Research demonstrated that serum creatine kinase activity was significantly elevated in untreated hypothyroid patients (mean CK 287 U/L vs. 98 U/L in euthyroid controls, P<0.001) [11]. This elevation reflects impaired creatine kinase clearance and altered enzyme isoform ratios, not enhanced phosphocreatine synthesis. Once thyroid hormone replacement normalizes CK levels, the muscle environment may be more receptive to creatine's ergogenic effects.

Clinical Takeaway for Athletes on Cytomel

Patients using liothyronine to achieve or maintain euthyroidism, and who also train for performance, may find that creatine works better once their T3 levels are optimized. Starting creatine before reaching a stable euthyroid state may yield submaximal benefit. A 6 to 8-week stabilization period on liothyronine before adding creatine is a reasonable clinical strategy.

Drug Interactions Checklist: What Actually Interacts with Liothyronine

Because patients on Cytomel often take multiple supplements, knowing which interactions are real helps put the creatine question in proper perspective.

Documented Interactions Worth Noting

• Calcium carbonate and calcium citrate: reduce liothyronine absorption by up to 20% when taken within 4 hours [7]. Separate by at least 4 hours.
• Iron supplements: ferrous sulfate binds thyroid hormones in the gut. Separate by at least 2 hours [12].
• Soy isoflavones: may reduce T3 absorption. Clinical significance is debated, but a 4-hour separation is reasonable.
• High-fiber psyllium: can bind bile acids and potentially reduce thyroid hormone absorption if taken simultaneously.
• Sympathomimetics (ephedrine, high-dose caffeine): combined with liothyronine, these can increase cardiac stimulation, raising heart rate and blood pressure beyond what either agent would produce alone.

Creatine does not appear on any of these mechanistic pathways. Its interaction profile with liothyronine is limited to the interpretive challenge of elevated serum creatinine.

Practical Dosing and Timing Guidance

Patients who receive approval from their prescriber to combine creatine with liothyronine can follow standard creatine dosing protocols without modification for the thyroid drug itself.

Standard Creatine Protocols

Loading phase (optional): 20 g/day divided into four 5 g doses for 5 to 7 days. This saturates muscle creatine stores faster but causes the largest short-term creatinine spike. Not recommended for patients with CKD or borderline renal function.

Maintenance phase: 3 to 5 g/day as a single dose. This can be taken at any time of day; the ergogenic effect is cumulative over days to weeks, not acute. Taking it with the post-workout meal has modest evidence of marginal benefit from insulin-mediated uptake, but the difference is small [13].

Liothyronine timing: Cytomel is typically taken once or twice daily, often in the morning on an empty stomach or 30 minutes before a meal to maximize absorption. Creatine does not interfere with this schedule regardless of when it is taken.

Hydration Considerations

Creatine increases intracellular water retention in muscle, which means total body water increases modestly (approximately 0.6 to 1.0 L during loading). Adequate hydration supports both creatine uptake and renal creatinine handling. Patients should target a minimum of 2.5 to 3 L of fluid daily while supplementing with creatine, particularly during the loading phase.

What to Tell Your Prescriber Before Starting Creatine on Cytomel

Open communication with the prescribing clinician prevents the most common problem in this combination, which is a misinterpreted lab result leading to unnecessary clinical intervention.

Tell your provider:

• The exact brand and dose of creatine you plan to use
• Whether you plan to do a loading phase or go straight to maintenance dosing
• Your current exercise intensity and frequency (because both affect CK and creatinine independently)
• Any other supplements you take, particularly iron, calcium, or stimulant-containing pre-workouts
• Your most recent kidney function labs and whether cystatin C was included

Your provider should document the conversation, establish a pre-creatine creatinine and cystatin C baseline, and note in your chart that elevated serum creatinine is an expected, non-pathological finding during creatine supplementation. That documentation protects you if a different clinician orders labs and sees the elevated creatinine without context.

Special Populations

Older Adults on Liothyronine

Hypothyroidism is more prevalent after age 60. Creatine has documented benefits in sarcopenia prevention in older adults, with a 2017 meta-analysis (9 RCTs, N=721) showing that creatine supplementation combined with resistance training produced significantly greater lean mass gains than resistance training plus placebo in adults over 50 [14]. However, age-related decline in GFR means baseline renal function should be carefully established before starting creatine in this group.

Women on Combination T4/T3 Therapy

Some women receive both levothyroxine and liothyronine (combination therapy). The same creatine interaction principles apply. Neither T4 nor T3 has a pharmacokinetic conflict with creatine. The lab interpretation issue remains identical.

Patients with Thyroid Cancer on Suppressive Therapy

Patients taking supratherapeutic liothyronine doses for TSH suppression after thyroidectomy are often in a borderline thyrotoxic state intentionally. These patients already face cardiovascular monitoring requirements. Adding creatine, which can modestly increase sympathomimetic sensitivity in combination with high T3, warrants an explicit conversation with their endocrinologist before starting.